Can features evaluated in the routine pathologic assessment of lymph node-negative estrogen receptor-positive stage I or II invasive breast cancer be used to predict the Oncotype DX recurrence score?

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples